These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 707951)

  • 1. [Influence of vehicules on enteral absorption of bepridil a new anti-anginal compound, cardiovascular responses after gastric or duodenal administration (author's transl)].
    Cosnier D; Constantin M; Nang LS; Piris R; Rispat G
    Ann Pharm Fr; 1978; 36(5-6):213-22. PubMed ID: 707951
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cinetic of biliary elimination of bepridil after intragastric or intraduodenal administration. Influence of different vehicles (author's transl)].
    Constantin M; Pognat JF; Cosnier D
    Ann Pharm Fr; 1978; 36(3-4):157-67. PubMed ID: 686626
    [No Abstract]   [Full Text] [Related]  

  • 3. Bepridil: a review of its pharmacology and clinical efficacy as an anti-anginal agent with anti-arrhythmic properties.
    Alpert JS; Coumel P; Greeff K; Krikler DM; Remme WJ; Schönbaum E; Verduyn CW
    Pharmatherapeutica; 1985; 4(4):195-222. PubMed ID: 2414784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of bepridil and other anti-anginals on cardiovascular modifications engendered by conditioned anxiety in the dog.
    Piris P; Beaughard M; Cosnier D; Labrid C
    Arch Int Pharmacodyn Ther; 1978 Sep; 235(1):147-64. PubMed ID: 104675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some membrane interactions with bepridil, a new antianginal agent.
    Labrid C; Grosset A; Dureng G; Mironneau J; Duchene-Marullaz P
    J Pharmacol Exp Ther; 1979 Dec; 211(3):546-54. PubMed ID: 41937
    [No Abstract]   [Full Text] [Related]  

  • 6. [A new antianginal drug, bepridil: efficacy estimation by exertion test during a double blind test against a placebo (author's transl)].
    Canicave JC; Deu J; Jacq J; Paillet R
    Therapie; 1980; 35(5):607-12. PubMed ID: 6970998
    [No Abstract]   [Full Text] [Related]  

  • 7. Electrophysiological profile of bepridil, a new anti-anginal drug with calcium blocking properties.
    Flammang D; Waynberger M; Jansen FH; Paillet R; Coumel P
    Eur Heart J; 1983 Sep; 4(9):657-54. PubMed ID: 6605854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequence of solubility alteration by salt effect on dissolution enhancement and biological response of a solid dispersion of an experimental antianginal drug.
    Nang LS; Cosnier D; Terrie G; Moleyre J
    Pharmacology; 1977; 15(6):545-50. PubMed ID: 594137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bepridil: hemodynamic and coronary effects on normal and/or ischemic myocardium in dogs (author's transl)].
    Berdeaux A; Kantelip JP; Eschalier A; Giudicelli JF; Duchene-Marullaz P
    J Pharmacol; 1980; 11(4):391-409. PubMed ID: 6970858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bepridil, a functional antagonist of beta1-adrenergic stimulation. Dissociated effects on cardiostimulation and lipolysis. (author's transl)].
    Constantin M; Beaughard M; Piris P; Labrid C
    J Pharmacol; 1981; 12(3):239-54. PubMed ID: 6116833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of Imolamin on hemodynamics and pacing induced angina pectoris (author's transl)].
    Leisch F; Bergmann H; Schützenberger W; Herbinger W
    Wien Med Wochenschr; 1980 Sep; 130(18):606-8. PubMed ID: 7008372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study of cardiovascular and antiarrhythmic effects of alizapride (author's transl)].
    Cheymol G; Mouillé P
    Sem Hop; 1982 Feb; 58(6):333-8. PubMed ID: 6280298
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacological properties of a new anti-anginal agent: amiodarone].
    Moret PR; Boufas D; Fournet PC
    Schweiz Med Wochenschr; 1969 Jul; 99(30):1090-5. PubMed ID: 5351143
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chronic administration of beta blocking agents: left ventricular hemodynamics in myocardial infarctions during exercise (author's transl)].
    Blümchen G; Esche HH
    Z Kardiol; 1981 Sep; 70(9):678-86. PubMed ID: 7303806
    [No Abstract]   [Full Text] [Related]  

  • 15. [A clinical trial of the effectiveness and tolerance of bepridil in unstable angina pectoris].
    Amat G; Boch C; Curnier JM; Colonna D
    Sem Hop; 1982 Dec; 58(45):2660-3. PubMed ID: 6297063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular actions after intravenous and intracoronary administration of the slow channel blocker bepridil.
    Verdouw PD; Scheffer MG
    Arzneimittelforschung; 1984; 34(1):21-5. PubMed ID: 6608356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-angina effect of the calcium antagonist bepridil in stable angina pectoris].
    Schneider W; Mehlhorn C; Kaltenbach M; Bussmann WD
    Z Kardiol; 1985 Jun; 74(6):341-7. PubMed ID: 3895761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness and duration of action of nifedipine in effort angina (author's transl)].
    Arosio G; Ciampalini G; Di Girolamo A; Ettori F; Fappani A; Oneglia C
    G Ital Cardiol; 1980; 10(9):1156-70. PubMed ID: 7461365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of plasma levels and the excretion of beclamide in normal human subjects [proceedings].
    Leach H; Lewis M; Luscombe DK; Nicholls PJ
    Br J Clin Pharmacol; 1975 Aug; 2(4):377P-378P. PubMed ID: 1234008
    [No Abstract]   [Full Text] [Related]  

  • 20. [Electrophysiologic effects of bepridil on the human heart].
    Valère PE; Belin A; Chentir T; Lehner JP; Guerot C; Tricot R
    Ann Cardiol Angeiol (Paris); 1982; 31(5):409-15. PubMed ID: 6984315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.